1. Home
  2. MLKN vs CMPX Comparison

MLKN vs CMPX Comparison

Compare MLKN & CMPX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo MillerKnoll Inc.

MLKN

MillerKnoll Inc.

HOLD

Current Price

$14.70

Market Cap

1.0B

ML Signal

HOLD

Logo Compass Therapeutics Inc.

CMPX

Compass Therapeutics Inc.

HOLD

Current Price

$1.84

Market Cap

927.5M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
MLKN
CMPX
Founded
1905
2014
Country
United States
United States
Employees
N/A
N/A
Industry
Office Equipment/Supplies/Services
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.0B
927.5M
IPO Year
1994
2020

Fundamental Metrics

Financial Performance
Metric
MLKN
CMPX
Price
$14.70
$1.84
Analyst Decision
Strong Buy
Analyst Count
0
9
Target Price
N/A
$14.57
AVG Volume (30 Days)
624.6K
12.2M
Earning Date
03-25-2026
05-06-2026
Dividend Yield
4.71%
N/A
EPS Growth
N/A
N/A
EPS
0.98
N/A
Revenue
$3,669,900,000.00
N/A
Revenue This Year
$5.94
N/A
Revenue Next Year
$3.78
$934.41
P/E Ratio
$14.80
N/A
Revenue Growth
1.14
N/A
52 Week Low
$13.77
$1.61
52 Week High
$23.18
$6.88

Technical Indicators

Market Signals
Indicator
MLKN
CMPX
Relative Strength Index (RSI) 37.13 26.23
Support Level $13.81 $1.61
Resistance Level $16.34 $3.54
Average True Range (ATR) 0.59 0.15
MACD -0.14 0.06
Stochastic Oscillator 9.63 46.05

Price Performance

Historical Comparison
MLKN
CMPX

About MLKN MillerKnoll Inc.

MillerKnoll Inc, formerly Herman Miller Inc researches, designs, manufactures, sells, and distributes interior furnishings across the globe. The Company has three reportable segments: Americas Contract, International Contract, and Global Retail. The company's products are sold through a variety of sources, including owned and independent contract furniture dealers, direct customer sales, owned and independent retailers, direct-mail catalogs, and the company's online stores. The independent retailer division generates the majority of the firm's overall sales.

About CMPX Compass Therapeutics Inc.

Compass Therapeutics Inc is a clinical-stage oncology-focused biopharmaceutical company that develops proprietary antibody therapeutics to engage the immune system to treat multiple human diseases. The company's scientific focus is on the relationship between angiogenesis, the immune system, and tumor growth. It is engaged in drug discovery by leveraging its proprietary antibody discovery engine to target the immune system and identify optimal combinations empirically broadly. Through StitchMabs and common light chain platforms, these combinatorial insights can be rapidly translated into tailored bispecifics with monoclonal-like manufacturability. Its pipeline is comprised of the following product candidates; CTX-009, CTX-471, CTX-10726, VEGF-A, Bispecific, and CTX-8371.

Share on Social Networks: